Trial Profile
A Phase II Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus in MRSA Positive Ulcers
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 20 Dec 2014
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Methicillin-resistant Staphylococcus aureus infections; Skin ulcer
- Focus Therapeutic Use
- 20 Dec 2014 New trial record